Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Mezigdomide, an investigational oral cereblon E3 ligase modulator, is demonstrating high efficacy in patients with relapsed/refractory multiple myeloma. Dr. Paul Richardson of Dana-Farber Cancer Institute describes the therapy as “CAR ... Read More
Continuous Coverage
Residents of Castroville, the historic “Little Alsace of Texas,” are mounting a sustained, grassroots campaign to secure a…
Reddit Thread Reveals Unusual Snapchat Story Dynamics Amid Tech Sector Scrutiny Snapchat’s story-sharing feature faces renewed scrutiny after…
Alpha-gal syndrome, a life-threatening meat allergy caused by tick bites, affects 450,000 individuals in the U.S., according to…
Universal’s “Masters of the Universe” opened to a 62% drop from its Disclosure Day expectations, marking one of…
The New York Knicks secured their first NBA championship since 1973 on June 13, 2026, defeating their opponents…
Medieval chronicler Eilmer of Malmesbury, often remembered for his failed 11th-century flight attempt, has been linked to the…
Global Affairs
At least six people were killed when two helicopters collided over Rio de Janeiro on June 14, 2026,…
Markets And Money
AI-driven automation is reducing job openings in the UK financial sector, according to De Telegraaf, with 23% of…
Digital Culture
Google DeepMind has launched a new Asia-Pacific accelerator program designed to provide startups with direct access to proprietary…
Science And Wellbeing
A new study published in this week’s journal reveals that physical activity declines among patients prescribed GLP-1 receptor…
Screen And Sound
Gwyneth Paltrow faces backlash for starring in luxury Israeli real estate ad, with critics accusing her of 'supporting…
Fixtures And Form
Donald Trump’s UFC 80th birthday event faces potential weather-related disruptions, with organizers preparing for a high-stakes clash between…
